Home/Filings/4/0000950170-24-089202
4//SEC Filing

Witzeman Michael D 4

Accession 0000950170-24-089202

CIK 0000019584other

Filed

Jul 31, 8:00 PM ET

Accepted

Aug 1, 3:42 PM ET

Size

8.3 KB

Accession

0000950170-24-089202

Insider Transaction Report

Form 4
Period: 2024-07-31
Witzeman Michael D
VP & Chief Financial Officer
Transactions
  • Exercise/Conversion

    Stock Option (right to buy with tandem tax withholding)

    2024-07-31$471.74/sh7,948$3,749,39029,885 total
    Exercise: $471.74Exp: 2025-10-29Capital Stock (7,948 underlying)
  • Tax Payment

    Capital Stock

    2024-07-31$560.99/sh7,225$4,053,1533,784 total
  • Exercise/Conversion

    Capital Stock

    2024-07-31$471.74/sh+7,948$3,749,39011,009 total
Footnotes (2)
  • [F1]Payment of purchase price and tax obligation on stock option exercise.
  • [F2]Vesting in three equal annual installments commencing 10/29/2021

Documents

1 file

Issuer

CHEMED CORP

CIK 0000019584

Entity typeother

Related Parties

1
  • filerCIK 0001699624

Filing Metadata

Form type
4
Filed
Jul 31, 8:00 PM ET
Accepted
Aug 1, 3:42 PM ET
Size
8.3 KB